The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: A critical review

Journal of Autoimmunity

Volumn 51, Issue , 2014, Pages 44-50

  Sumida, Takayuki ^a   Tsuboi, Hiroto ^a   Iizuka, Mana ^a   Hirota, Tomoya ^a   Asashima, Hiromitsu ^a   Matsumoto, Isao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Anti M3R antibodies; M3R; M3R induced sialadenitis; M3R reactive T cells; Sj gren's syndrome

Indexed keywords

AUTOANTIGEN; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 17; MUSCARINIC M3 RECEPTOR; RECEPTOR ANTIBODY; SYNTHETIC PEPTIDE; AUTOANTIBODY;

B LYMPHOCYTE; CELL TRANSFER; DISEASE SEVERITY; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIALOADENITIS; SJOEGREN SYNDROME; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; ANTIBODY SPECIFICITY; AUTOIMMUNITY; DISEASE MODEL; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MOUSE; SJOGREN'S SYNDROME; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; EPITOPES, B-LYMPHOCYTE; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MICE; ORGAN SPECIFICITY; RECEPTOR, MUSCARINIC M3; SJOGREN'S SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 84901256461     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.12.012     Document Type: Review

References (41)

1. Dawson L., Tobin A., Smith P., Gorton T. Antimuscarinic antibodies in Sjögren's syndrome. Arthritis Rheum 2005, 52:2984-2995.
2. Li J., Ha Y.M., Ku N.Y., Choi S.Y., Lee S.J., Oh S.B., et al. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome. Lab Invest 2004, 84:1430-1438.
3. Scarselli M., Li B., Kim S.K., Wess J. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation. JBiol Chem 2007, 282:7385-7396.
4. Sumida T., Tsuboi H., Iizuka M., Nakamura Y., Matsumoto I. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sögren's syndrome. Autoimmun Rev 2010, 9:615-617.
5. Sumida T., Yonaha F., Maeda T., Tanabe E., Koike T., Tomioka H., et al. Tcell receptor repertoire of infiltrating T cells in lips of Sjogren's syndrome patients. JClin Invest 1992, 89:681-685.
6. Yonaha F., Sumida T., Maeda T., Tomioka H., Koike T., Yoshida S. Restricted junctional usage of T cell receptor Vβ2 and Vβ13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjogren's syndrome. Arthritis Rheum 1992, 35:1362-1367.
7. Dwyer E., Itescu S., Winchester R. Characterization of the primary structure of T cell receptor β chains in cells infiltrating the salivary gland in the sicca syndrome of HIC-1 infection. JClin Invest 1993, 92:495-502.
8. Legras F., Martin T., Knapp A.-M., Pasquali J.-L. Infiltrating T cells from patients with primary Sjogern's syndrome express restricted or unrestricted T cell receptor Vβ regions depending on the stage of the disease. Eur J Immunol 1994, 24:181-185.
9. Sumida T., Skamaki T., Yonaha F., Maeda T., Namekawa T., Nawata, et al. LA-DR alleles in patients with Sjogren's syndrome over-representing Vβ2 and Vβ13 genes in the labial salivary glands. Br J Rheumatol 1994, 33:420-424.
10. Sumida T., Kita Y., Yonaha F., Maeda T., Iwamoto I., Yoshida S. Tcell receptor Vα repertoire of infiltrating T cells in labial salivary glands from patients with Sjogren's syndrome. JRheumatol 1994, 21:1655-1661.
11. Smith M.D., Lamour A., Boylston A., Lancaster F.C., Pennec Y.L., van Agthoven A., et al. Selective expansion of Vβ families by T cells in the blood and salivary gland infiltrate of patients with primary Sjogren's syndrome. JRheumatol 1994, 21:1832-1837.
12. Sumida T., Matsumoto I., Murata H., Namekawa T., Matsumura R., Tomioka H., et al. TCR in Fas-sensitive T ells from labial salivary glands of patients with Sjogren's syndrome. JImmunol 1997, 158:1020-1025.
13. Matsumoto I., Okada S., Kuraoda K., Iwamoto I., Saito Y., Tokuhisa T., et al. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. Int J Mol Med 1999, 4:519-527.
14. Furrie E., Doherty M., Kershaw A., Crighton A., Morley K., Kay R. Molecular evidence of antigen-driven Vβ13.2 T cells in the lip biopsies and peripheral blood of anti-52kDa Ro autoantibody positive Sjogren's syndrome patients. Arthritis Rheum 1999, S403.
15. Mizushima N., Kohsaka H., Tsubota K., Saito I., Miyasaka N. Diverse T cell receptor β gene usage by infiltrating T cells in the lacrimal glands of Sjogren's syndrome. Clin Exp Immunol 1995, 101:33-38.
16. Matsumoto I., Tsubota K., Satake Y., Kita Y., Matsumura R., Murata H., et al. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome. JClin Invest 1996, 97:1969-1977.
17. Murata H., Kita Y., Sakamoto A., Matsumoto I., Matsumura R., Sugiyama T., et al. Limited T cell receptor repertoire of infiltrating T cells in the kidneys of Sjogren's syndrome patients with interstitial nephritis. JImmunol 1995, 155:4084-4089.
18. Kay R.A., Hay E.M., Dyer P.A., Dennett C., Green L.M., Bernstein R.M., et al. An abnormal T cell repertoire in hypergammaglobulinemic primary Sjogren's syndrome. Clin Exp Immunol 1991, 85:262-264.
19. Kay R.A., Hutchings C.J., Ollier W.E.R. Asubset of Sjogren's syndrome associates with the TCRBV13S2 locus but not the TCRBV2S1 locus. Hum Immunol 1995, 42:328-330.
20. Sumida T., Namekawa T., Maeda T., Nishioka K. New T cell epitope of Ro/SS-A 52kDa protein in labial salivary glands from patients with Sjogren's syndrome. Lancet 1996, 348:1667.
21. Sumida T., Kato T., Hasunuma T., Maeda T., Nishioka K., Matsumoto I. Regulatory T cell epitope recognized by T cells from labial salivary glands of patients with Sjogen's syndrome. Arthritis Rheum 1997, 40:2271-2273.
22. Matsumoto I., Maeda T., Takemoto Y., Hashimoto Y., Kimura F., Iwamoto I., et al. α-amylase functions as a salivary gland-specific self T cell epitope in patients with Sjogren's syndrome. Int J Mol Med 1999, 3:485-490.
23. Naito Y., Matsumoto I., Wakamatsu E., Goto D., Ito S., Tsutsumi A., et al. Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjogren's syndrome. Ann Rheum Dis 2005, 65:269-271.
24. Sumida T., Tsuboi H., Iizuka M., Asashima H., Matsumoto I. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Mod Rheumatol 2013, 23:841-845.
25. Sumida T., Iizuka M., Asashima H., Tsuboi H., Matsumoto I. Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome. Presse Med 2012, 4:e461-e466.
26. Bacman S.R., Berra A., Sterin-Borda L., Borda E.S. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 1998, 17:1135-1142.
27. Waterman S.A., Gordon T.P., Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000, 43:1647-1654.
28. Gao J., Cha S., Jonsson R., Opalko J., Peck A.B. Detection of anti-type 3 muscarinic acetylcholine receptor antibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum 2004, 50:2615-2621.
29. Naito Y., Matsumoto I., Wakamatsu E., Goto D., Sugiyama T., Matsumura R., et al. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Ann Rheum Dis 2005, 64:510-511.
30. Marczinovits I., Kovacs L., Gyorgy A., Toth G.K., Dorgai L., Molnar J., et al. Apeptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjögren's syndrome. JAutoimmun 2005, 24:47-54.
31. Kovacs L., Marczinovits I., Gyorgy A., Toth G.K., Dorgai L., Pal J., et al. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3213-228 in primary Sjögren's syndrome. Rheumatology 2005, 44:1021-1025.
32. Nakamura Y., Wakamatsu E., Matsumoto I., Tomiita M., Kohno Y., Mori M., et al. High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjögren's syndrome. Ann Rheum Dis 2008, 67:136-137.
33. Tsuboi H., Matsumoto I., Wakamatsu E., Nakamura Y., Iizuka M., Hayashi T., et al. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren's syndrome. Clin Exp Immunol 2010, 162:53-61.
34. He J., Qiang L., Ding Y., Wei P., Li Y.N., Hua H., et al. The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjogren's syndrome. Clin Exp Rheumatol 2012, 30:322-326.
35. Cavill D., Waterman S.A., Gordon T.P. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome. Scand J Immunol 2004, 59:261-266.
36. Dawson L.J., Stanbury J., Venn N., Hasdimir B., Rogers S.N., Smith P.M. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 2006, 54:1165-1173.
37. Koo N.Y., Li J., Hwang S.M., Choi S.Y., Lee S.J., Oh S.B., et al. Functional epitopes of muscarinic type 3 receptor which interacts with autoantibodies from Sjögren's syndrome patients. Rheumatology 2008, 47:828-833.
38. Tsuboi H., Nakamura Y., Iizuka M., Matsuo N., Matsumoto I., Sumida T. Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor. Mod Rheumatol 2012, 22:264-271.
39. Jin M., Hwang S.-M., Davies A.J., Shin Y., Bae J.-S., Lee J.-H., et al. Autoantibodies in primary Sjogren's syndrome patients induce internalization of muscarinic type 3 receptors. Biochim Biophys Acta 2012, 1822:161-167.
40. Iizuka M., Wakamatsu E., Tsuboi H., Nakamura Y., Hayashi T., Matsui M., et al. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome. JAutoimmun 2010, 35:383-389.
41. Iizuka M., Tsuboi H., Matuo N., Kondo Y., Asashima H., Matsui M., et al. The crucial roles of IFN-γ in the development of M3 muscarinic acetylcholine receptor induced Sjögren's syndrome-like sialadenitis. Mod Rheumatol 2013, 23:614-616. Epub 2012 Oct 26.